Ted L. Underiner

944 citations

31 papers · 763 indexed · h-index 18

Co-authors: Harlan L. Goering Sheila Miknyoczki Torsten Herbertz Xavier Creary Thelma S. Angeles Mark S. Albom Bruce D. Dorsey Bruce Ruggeri
Topics: Angiogenesis and VEGF in Cancer (5 papers)Chemical Synthesis and Analysis (4 papers)Liver physiology and pathology (4 papers)
Cited by: Organic Chemistry Hepatology Molecular Biology
Journals: Journal of the American Chemical Society Blood Journal of Medicinal Chemistry
Partner nations: United States France

In The Last Decade

Ted L. Underiner

31 papers receiving 712 citations

Peers

Countries citing papers authored by Ted L. Underiner

Since Specialization

Citations

This map shows the geographic impact of Ted L. Underiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted L. Underiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted L. Underiner more than expected).

Fields of papers citing papers by Ted L. Underiner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted L. Underiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted L. Underiner. The network helps show where Ted L. Underiner may publish in the future.

Co-authorship network of co-authors of Ted L. Underiner

This figure shows the co-authorship network connecting the top 25 collaborators of Ted L. Underiner. A scholar is included among the top collaborators of Ted L. Underiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted L. Underiner. Ted L. Underiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improvement of Inhibitor Identification for Heat Shock Protein 90α by Utilizing a Red-Shifted Fluorescence Polarization Probe 2012 ·Assay and Drug Development Technologies ·Jie Qian,Beverly P. Holskin,Jay Theroff,Ted L. Underiner,Sheryl L. Meyer,Thelma S. Angeles	1
2	Methanesulfonamido-cyclohexylamine derivatives of 2,4-diaminopyrimidine as potent ALK inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Craig A. Zificsak,Jay Theroff,Lisa D. Aimone,Thelma S. Angeles,Mark S. Albom,Mangeng Cheng,Eugen F. Mesaros,Gregory R. Ott,Matthew R. Quail,Ted L. Underiner,Weihua Wan,Bruce D. Dorsey	18
3	2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: Modification of target structure to minimize reactive metabolite formation 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Mark S. Albom,Thelma S. Angeles,Henry J. Breslin,Diane E. Gingrich,Zeqi Huang,Joseph G. Lisko,Jennifer L. Mason,Karen L. Milkiewicz,(unknown),Ted L. Underiner,Gregory J. Wells,Kevin J. Wells‐Knecht,Bruce D. Dorsey	17
4	Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases 2011 ·Bioorganic & Medicinal Chemistry Letters ·Craig A. Zificsak,Diane E. Gingrich,Henry J. Breslin,Derek Dunn,Karen L. Milkiewicz,Jay Theroff,(unknown),Ted L. Underiner,(unknown),Lisa D. Aimone,Mark S. Albom,Jennifer L. Mason,(unknown),Jean Husten,Thelma S. Angeles,James P. Finn,(unknown),Teresa M. O’Kane,Paweł Dobrzański,Bruce D. Dorsey	18
5	Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent 2011 ·Journal of Medicinal Chemistry ·Robert L. Hudkins,(unknown),Allison L. Zulli,Ted L. Underiner,Thelma S. Angeles,Lisa D. Aimone,Mark S. Albom,Hong Chang,Sheila Miknyoczki,Kathryn Hunter,Susan Jones‐Bolin,Hugh Zhao,Edward R. Bacon,John P. Mallamo,Mark A. Ator,Bruce Ruggeri	38
6	Improvement in oral bioavailability of 2,4-diaminopyrimidine c-Met inhibitors by incorporation of a 3-amidobenzazepin-2-one group 2011 ·Bioorganic & Medicinal Chemistry ·Karen L. Milkiewicz,Lisa D. Aimone,Mark S. Albom,Thelma S. Angeles,(unknown),Jennifer V. Grobelny,Jean Husten,(unknown),Sheila Miknyoczki,S. N. Prasanna Murthy,(unknown),Ted L. Underiner,(unknown),(unknown),(unknown),Bruce D. Dorsey	11
7	Fused bicyclic derivatives of 2,4-diaminopyrimidine as c-Met inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Mark S. Albom,Thelma S. Angeles,Jean Husten,Joseph G. Lisko,Robert J. McHugh,Karen L. Milkiewicz,S. N. Prasanna Murthy,Gregory R. Ott,Jay Theroff,Rabindranath Tripathy,Ted L. Underiner,Craig A. Zificsak,Bruce D. Dorsey	22
8	2,4-Diaminopyrimidine inhibitors of c-Met kinase bearing benzoxazepine anilines 2010 ·Bioorganic & Medicinal Chemistry Letters ·Craig A. Zificsak,Jay Theroff,Lisa D. Aimone,Mark S. Albom,Thelma S. Angeles,(unknown),(unknown),Jennifer V. Grobelny,Torsten Herbertz,Jean Husten,Laura S. Kocsis,(unknown),Sheila Miknyoczki,S. N. Prasanna Murthy,(unknown),Ted L. Underiner,Kevin J. Wells‐Knecht,(unknown),(unknown),Bruce D. Dorsey	13
9	Discovery of Small Molecule c-Met Inhibitors: Evolution and Profiles of Clinical Candidates 2010 ·Anti-Cancer Agents in Medicinal Chemistry ·Ted L. Underiner,Torsten Herbertz,Sheila Miknyoczki	121
10	8-THP-DHI analogs as potent Type I dual TIE-2/VEGF-R2 receptor tyrosine kinase inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Robert L. Hudkins,Allison L. Zulli,Ted L. Underiner,Thelma S. Angeles,Lisa D. Aimone,Sheryl L. Meyer,Daniel Pauletti,Hong Chang,E.V. Fedorov,Steven C. Almo,А.А. Федоров,Bruce Ruggeri	9
11	Synthesis and structure–activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase 2010 ·Bioorganic & Medicinal Chemistry ·Karen L. Milkiewicz,(unknown),Mark S. Albom,Thelma S. Angeles,Mangeng Cheng,Arup K. Ghose,Renee C. Roemmele,Jay Theroff,Ted L. Underiner,Craig A. Zificsak,(unknown)	20
12	TIE-2/VEGF-R2 SAR and in vitro activity of C3-acyl dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole analogs 2008 ·Bioorganic & Medicinal Chemistry Letters ·Ted L. Underiner,Bruce Ruggeri,Lisa D. Aimone,Mark S. Albom,Thelma S. Angeles,Hong Chang,Robert L. Hudkins,Kathryn Hunter,Kurt A. Josef,Candy Robinson,(unknown),Shi Yang,Allison L. Zulli	8
13	Design and synthesis of dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinases 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Allison L. Zulli,Edward R. Bacon,Ted L. Underiner,Candy Robinson,Hong Chang,Sheila Miknyoczki,Jennifer V. Grobelny,Bruce Ruggeri,Shi Yang,Mark S. Albom,Thelma S. Angeles,Lisa D. Aimone,Robert L. Hudkins	15
14	CEP-11981: A potent TIE-2/Pan-VEGF-R inhibitor with broad kinase inhibitory activity exhibits significant antitumor and antiangiogenic efficacy in preclinical tumor models 2007 ·Molecular Cancer Therapeutics ·Bruce Ruggeri,Ted L. Underiner,Diane E. Gingrich,Robert L. Hudkins,Thelma S. Angeles,Mark S. Albom,Hong Chang,Candy Robinson,Kathryn Hunter,Paweł Dobrzański,Susan Jones‐Bolin,Lisa D. Aimone,Mark A. Ator,Jean‐Marc Herbert,Françoise Bono,Paul Schaefer,Pierre Casellas,(unknown),John P. Mallamo,Jeffry L. Vaught	2
15	Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells 2005 ·Blood ·Weihua Wan,Mark S. Albom,Lihui Lü,Matthew R. Quail,(unknown),(unknown),(unknown),Beverly P. Holskin,Thelma S. Angeles,Ted L. Underiner,Sheryl L. Meyer,Robert L. Hudkins,Bruce D. Dorsey,Mark A. Ator,Bruce Ruggeri,Mangeng Cheng	85
16	CT2108A and B: New Fatty Acid Synthase Inhibitors as Antifungal Agents 2003 ·Journal of Natural Products ·(unknown),Robert Raulli,(unknown),Paul Actor,Ted L. Underiner,(unknown),Ursula Mocek,R. L. Cihlar,Sheldon E. Broedel	25
17	First Synthesis of Cytotoxic 8,9-Secokaurene Diterpenoids. An Enantioselective Route to (−)-O-Methylshikoccin and (+)-O-Methylepoxyshikoccin 1997 ·Journal of the American Chemical Society ·Leo A. Paquette,(unknown),Ralf J. Braun,Ted L. Underiner,Klaus Fuchs	26
18	Cross coupling of allylic derivatives. 16. Regiochemistry of cross coupling of the isomeric (E,E)-3,5-heptadien-2-yl and (E,E)-2,5-heptadien-4-yl pivalates with organocopper and Grignard reagents 1990 ·The Journal of Organic Chemistry ·Ted L. Underiner,Harlan L. Goering	19
19	Cross coupling of allylic derivatives. 15. Regio- and stereospecfic cross-coupling reactions of dienyl allylic N-phenylcarbamates with phenylcopper reagents 1989 ·The Journal of Organic Chemistry ·Ted L. Underiner,Harlan L. Goering	6
20	Alkylation of allylic derivatives. 14. Relationship of double-bond configuration between reactant and product for cross-coupling reactions of Z-allylic carboxylates with organocopper reagents 1989 ·The Journal of Organic Chemistry ·Ted L. Underiner,(unknown),(unknown),(unknown),Harlan L. Goering	30

About Ted L. Underiner

Ted L. Underiner is a scholar working on Toxicology, Hepatology and Organic Chemistry, having authored 31 papers that have together received 763 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (5 papers), Chemical Synthesis and Analysis (4 papers) and Liver physiology and pathology (4 papers). The work is most often cited by research in Organic Chemistry (331 citations), Hepatology (85 citations) and Molecular Biology (388 citations). Ted L. Underiner has collaborated with scholars based in United States and France. Frequent co-authors include Harlan L. Goering, Sheila Miknyoczki, Torsten Herbertz, Xavier Creary, Thelma S. Angeles, Mark S. Albom, Bruce D. Dorsey, Bruce Ruggeri, Allan M. Ferguson and David E. Patterson. Their work appears in journals such as Journal of the American Chemical Society, Blood and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact